FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2977888959> ?p ?o ?g. }

• W2977888959 endingPage "e16950" @default.
• W2977888959 startingPage "e16950" @default.
• W2977888959 abstract "Abstract Background: Anorexia is a common cause of malnutrition and is associated with negative effects on the quality of life (QOL) for patients with cancer. Management of appetite is the key to improving both the QOL and the prognosis for such patients. Yukgunja-tang (YGJT) is a traditional herbal medicine extensively prescribed in Korea as a remedy for various gastrointestinal syndromes. Currently, no standardized herbal medicine treatment exists for patients with cancer who are suffering from anorexia after surgery, chemotherapy, and/or radiotherapy. For that reason, this study aims to examine the efficacy and the safety of using YGJT to treat anorexia in such patients and to establish whether or not YGJT can be recommended as the primary therapy. Methods: We will enroll 52 cancer patients diagnosed with anorexia. The enrolled participants will be randomly allocated to 2 groups: The control group will receive nutrition counseling, and the YGJT group will receive nutrition counseling and be administered YGJT at a dose of 3 g twice a day for 4 weeks (a total of 56 doses of 3.0 g per dose). The primary outcome of this study is the change in the score on the anorexia/cachexia subscale (A/CS) of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT). The secondary outcomes are the changes in the FAACT score with the A/CS score excluded, the score on the Visual Analogue Scale (VAS) for appetite, the weight and the body mass index (BMI), and laboratory tests for compounds such as leptin, tumor necrosis factor-α (TNF-α), ghrelin, and IL-6. All variables related to the safety assessment, such as vital signs, electrocardiography results, laboratory test results (CBC, chemistry, urine test), and adverse events, will be documented on the case report form (CRF) at every visit. Conclusion: This study is the first randomized controlled trial to investigate the efficacy and the safety of using YGJT for treating patients with cancer-related anorexia in Korea. We designed this study based on previous research about YGJT. This study will serve as a pilot and provide data for planning further clinical trials on herbal medicine and cancer-related anorexia. Trial registration: Clinical Research Information Service (CRIS), Republic of Korea, ID: KCT0002847. Registered retrospectively on 3 April 2018." @default.
• W2977888959 created "2019-10-10" @default.
• W2977888959 creator A5023652525 @default.
• W2977888959 creator A5036138930 @default.
• W2977888959 creator A5072986545 @default.
• W2977888959 creator A5079641212 @default.
• W2977888959 creator A5085124109 @default.
• W2977888959 date "2019-10-01" @default.
• W2977888959 modified "2023-09-27" @default.
• W2977888959 title "Efficacy and safety of Yukgunja-Tang for treating anorexia in patients with cancer" @default.
• W2977888959 cites W1575888812 @default.
• W2977888959 cites W1970611805 @default.
• W2977888959 cites W1977330961 @default.
• W2977888959 cites W1986903185 @default.
• W2977888959 cites W1988293412 @default.
• W2977888959 cites W1988924200 @default.
• W2977888959 cites W1992818577 @default.
• W2977888959 cites W1995596500 @default.
• W2977888959 cites W1997124843 @default.
• W2977888959 cites W2008036643 @default.
• W2977888959 cites W2016590975 @default.
• W2977888959 cites W2017361979 @default.
• W2977888959 cites W2017973393 @default.
• W2977888959 cites W2028802149 @default.
• W2977888959 cites W2032247757 @default.
• W2977888959 cites W2044122086 @default.
• W2977888959 cites W2052279009 @default.
• W2977888959 cites W2068008235 @default.
• W2977888959 cites W2090937967 @default.
• W2977888959 cites W2090954628 @default.
• W2977888959 cites W2098535893 @default.
• W2977888959 cites W2132740821 @default.
• W2977888959 cites W2145194160 @default.
• W2977888959 cites W2312244831 @default.
• W2977888959 cites W235910007 @default.
• W2977888959 cites W2463786643 @default.
• W2977888959 cites W2548315011 @default.
• W2977888959 cites W2779430635 @default.
• W2977888959 cites W821861213 @default.
• W2977888959 doi "https://doi.org/10.1097/md.0000000000016950" @default.
• W2977888959 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6783206" @default.
• W2977888959 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31577697" @default.
• W2977888959 hasPublicationYear "2019" @default.
• W2977888959 type Work @default.
• W2977888959 sameAs 2977888959 @default.
• W2977888959 citedByCount "8" @default.
• W2977888959 countsByYear W29778889592020 @default.
• W2977888959 countsByYear W29778889592021 @default.
• W2977888959 countsByYear W29778889592022 @default.
• W2977888959 countsByYear W29778889592023 @default.
• W2977888959 crossrefType "journal-article" @default.
• W2977888959 hasAuthorship W2977888959A5023652525 @default.
• W2977888959 hasAuthorship W2977888959A5036138930 @default.
• W2977888959 hasAuthorship W2977888959A5072986545 @default.
• W2977888959 hasAuthorship W2977888959A5079641212 @default.
• W2977888959 hasAuthorship W2977888959A5085124109 @default.
• W2977888959 hasBestOaLocation W29778889591 @default.
• W2977888959 hasConcept C121608353 @default.
• W2977888959 hasConcept C126322002 @default.
• W2977888959 hasConcept C159110408 @default.
• W2977888959 hasConcept C1862650 @default.
• W2977888959 hasConcept C2777704314 @default.
• W2977888959 hasConcept C2778654693 @default.
• W2977888959 hasConcept C2779951463 @default.
• W2977888959 hasConcept C2780221984 @default.
• W2977888959 hasConcept C511355011 @default.
• W2977888959 hasConcept C544821477 @default.
• W2977888959 hasConcept C551997983 @default.
• W2977888959 hasConcept C71924100 @default.
• W2977888959 hasConcept C75908981 @default.
• W2977888959 hasConceptScore W2977888959C121608353 @default.
• W2977888959 hasConceptScore W2977888959C126322002 @default.
• W2977888959 hasConceptScore W2977888959C159110408 @default.
• W2977888959 hasConceptScore W2977888959C1862650 @default.
• W2977888959 hasConceptScore W2977888959C2777704314 @default.
• W2977888959 hasConceptScore W2977888959C2778654693 @default.
• W2977888959 hasConceptScore W2977888959C2779951463 @default.
• W2977888959 hasConceptScore W2977888959C2780221984 @default.
• W2977888959 hasConceptScore W2977888959C511355011 @default.
• W2977888959 hasConceptScore W2977888959C544821477 @default.
• W2977888959 hasConceptScore W2977888959C551997983 @default.
• W2977888959 hasConceptScore W2977888959C71924100 @default.
• W2977888959 hasConceptScore W2977888959C75908981 @default.
• W2977888959 hasIssue "40" @default.
• W2977888959 hasLocation W29778889591 @default.
• W2977888959 hasLocation W29778889592 @default.
• W2977888959 hasLocation W29778889593 @default.
• W2977888959 hasLocation W29778889594 @default.
• W2977888959 hasLocation W29778889595 @default.
• W2977888959 hasOpenAccess W2977888959 @default.
• W2977888959 hasPrimaryLocation W29778889591 @default.
• W2977888959 hasRelatedWork W173368156 @default.
• W2977888959 hasRelatedWork W1750391852 @default.
• W2977888959 hasRelatedWork W2043031858 @default.
• W2977888959 hasRelatedWork W2068515995 @default.
• W2977888959 hasRelatedWork W2121844185 @default.
• W2977888959 hasRelatedWork W2749876332 @default.
• W2977888959 hasRelatedWork W2963657781 @default.

• next